Cargando…
DHP23002 as a next generation oral paclitaxel formulation for pancreatic cancer therapy
OBJECTIVE: This study aimed to develop a new oral paclitaxel formulation (DHP23002) and to evaluate its absorption and antitumor effects in a pancreatic tumor mouse model. METHODS: To investigate the oral absorption of DHP23002, a newly developed lipid-based orally active paclitaxel formulation, a p...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863550/ https://www.ncbi.nlm.nih.gov/pubmed/31743348 http://dx.doi.org/10.1371/journal.pone.0225095 |